Prothena Corp Plc (NASDAQ: PRTA) stock suffered a major decline of -13.2% on 1/8/24. The shares closed at $35.28. Moreover, exceptionally high trading volume at 478% of normal accompanied the decline. The stock has declined […]
On 1/8/24, Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock enjoyed a major increase of 10.9%, closing at $39.48. Moreover, this advance was accompanied by exceptionally high trading volume at 314% of normal. Relative to the market […]
Biolife Solutions Inc (NASDAQ: BLFS) stock closed at $17.24 on 1/8/24 after a major increase of 10.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 207% of normal. The stock has risen […]
Extremely significant positive changes in Baxter International Inc (NYSE: BAX) investment behavior have recently occurred: positive upside/downside volume developed, the stock’s recent price rise disrupted its longer term downtrend, and the stock rose on very […]
TechPrecision Corp (NASDAQ: TPCSD) stock closed at $4.46 on 1/8/24 after a major decline of -14.7%. Moreover, trading volume in this decline was exceptionally high at 495% of normal. The stock has been weak relative […]
Sage Therapeutics Inc (NASDAQ: SAGE) stock enjoyed a major increase of 16.9% on 1/8/24. The shares closed at $25.10. Moreover, trading volume in this advance was unusually high at 163% of normal. The stock has […]
Revance Therapeutics Inc (NASDAQ: RVNC) stock suffered a major decline of -15.6% on 1/8/24. The shares closed at $7.05. Moreover, exceptionally high trading volume at 253% of normal accompanied the decline. The stock has declined […]
On 1/8/24, Pacific Biosciences of Californi (NASDAQ: PACB) stock suffered a major decline of -18.5%, closing at $7.66. Moreover, trading volume in this decline was exceptionally high at 375% of normal. The stock has been […]
ProPhase Labs Inc (NASDAQ: PRPH) stock enjoyed a major increase of 10.7% on 1/8/24. The shares closed at $5.26. Moreover, trading volume in this advance was exceptionally high at 201% of normal. The stock has […]
On 1/8/24, Avid Bioservices Inc (NASDAQ: CDMO) stock enjoyed a major increase of 10.5%, closing at $6.63. However, this advance was accompanied by unusually low trading volume at 63% of normal. Relative to the market […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research